Lisinopril Market Size, Share & Trends Analysis Report By Product
Developed by experienced analysts, this report offers in-depth insights for understanding competition and customer behavior in the lisinopril industry.
What Is The Current Outlook For The Lisinopril Market By 2025?
The lisinopril market size has grown strongly in recent years. It will grow from $1.76 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increased accessibility, lifestyle shifts, increased screening programs, increased accessibility of generic lisinopril, and increased patient adherence.
The lisinopril market size is expected to see strong growth in the next few years. It will grow to $2.35 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to rising prevalence of hypertension and cardiovascular diseases, generic versions and cost-effectiveness, growing awareness and early diagnosis, growing demand for effective treatments, and aging population. Major trends in the forecast period include innovations in drug delivery, need for enhanced and patient-centric drug delivery approaches, demand for cost-effective solutions, demand for effective treatments for heart failure, and demand for effective treatments for diabetic kidney disease.
Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp
What Are The Key Driving Factors For The Growth Of The Lisinopril Market?
The growing prevalence of cardiovascular diseases is expected to propel the growth of the lisinopril market going forward. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels. The growing prevalence of cardiovascular diseases can be attributed to several factors, such as population growth and aging, risk factors, and lack of implementation of proven prevention and treatment strategies. Lisinopril helps manage cardiovascular diseases primarily through its ability to lower blood pressure and reduce the strain on the heart and kidneys. This inhibits the production of angiotensin II, facilitates the dilation of blood vessels, reduces blood volume, and protects organs from damage. For instance, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, ischemic heart diseases resulted in 5,302 deaths, showing a slight increase from 5,290 deaths in 2022. Therefore, the growing prevalence of cardiovascular diseases is driving the growth of the lisinopril market.
Global Lisinopril Market Report Segmentation
The lisinoprilmarket covered in this report is segmented —
1) By Brand: Zestoretic; Prinivil; Zestril; Other Brands
2) By Disease: Hypertension; Heart Failure; Heart Attack; Strokes; Diabetic Kidney Disease; Other Diseases
3) By Dosage: Tablet; Liquid; Other Dosages
4) By Population Type: Children; Adults
5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Zestoretic: Different Dosage Forms; Generic Versions Of Zestoretic
2) By Prinivil: Different Dosage Forms; Generic Versions Of Prinivil
3) By Zestril: Different Dosage Forms; Generic Versions Of Zestril
4) By Other Brands: International Brand Variants; Combination Drug Formulations
Who Are The Leading Players In The Lisinopril Market?
Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Hetero Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Metrochem API Private Limited, Calyx Chemicals & Pharmaceuticals Limited, Farmhispania Group, Zydus Cadila Healthcare Ltd., Qingdao Qingmei Biotech Co. Ltd., LGM Pharma LLC, Amara Labs Pvt., Sms Lifesciences
View the full lisinopril market report here:
https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report
Which Region Is Projected To Hold The Largest Market Share In The Global Lisinopril Market By 2029?
North America was the largest region in the lisinopril market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Americas +1 310–496–7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment